Mitochondrial dysfunction plays an important role in the pathogenesis of neurodegenerative diseases, numerous other disease states and senescence. The ability to monitor reactive oxygen species (ROS) within tissues and over time in animal model systems is of significant research value. Recently, redox-sensitive fluorescent proteins have been developed. Transgenic flies expressing genetically encoded redox-sensitive GFPs (roGFPs) targeted to the mitochondria function as a useful in vivo assay of mitochondrial dysfunction and ROS. We have generated transgenic flies expressing a mitochondrial-targeted roGFP2, demonstrated its responsiveness to redox changes in cultured cells and in vivo and utilized this protein to discover elevated ROS as a contributor to pathogenesis in a characterized neurodegeneration mutant and in a model of mitochondrial encephalomyopathy. These studies identify the role of ROS in pathogenesis associated with mitochondrial disease and demonstrate the utility of genetically encoded redox sensors in Drosophila.
Introduction
An increase in the level of reactive oxygen species (ROS) is known to contribute to the pathogenesis of several neurodegenerative diseases, including Alzheimer's, Parkinson's and Huntington's diseases, as well Amyotrophic lateral sclerosis and premature aging (Emerit et al., 2004; Halliwell, 2006) . Natural antioxidant systems serve as a defense against oxidative stress. When the production of ROS overwhelms antioxidant mechanisms damage to cellular macromolecules can occur resulting in accumulation of unfolded and misfolded proteins, membrane instability and DNA mutations. All of these are implicated in aging/senescence and in various pathological processes resulting from neurodegenerative diseases. In addition to direct oxidation, ROS can also activate numerous signaling pathways that increase apoptosis (Allen and Tresini, 2000; Li et al., 2008; Temkin and Karin, 2007) .
Since ROS are involved in a broad range of physiological and pathological processes, the measurement of ROS is critical for the investigation of the occurrence, development and outcome of diseases. Thus, numerous assays have been developed to measure ROS, each having distinct advantages and limitations. Among the most promising are genetically encoded redox sensors (Hanson et al., 2004) , which have recently proven functional in mammalian cells (Dooley et al., 2004) , Arabidopsis (Maughan et al., 2010; Meyer et al., 2007; Rosenwasser et al., 2010; Schwarzlander et al., 2009) , and in mice (Guzman et al., 2010) . Redox sensors were engineered with pairs of cysteine residues on adjacent surfaces of the fluorophore barrel structure such that excitation ratios are affected by the formation of disulfide linkages; therefore, the population of expressed roGFPs serve as a ratiometric probe of the redox status (Cannon and Remington, 2008; Dooley et al., 2004; Hanson et al., 2004) . Here, we report the generation and characterization of transgenic flies expressing a genetically expressed roGFP probe to measure ROS. The principal advantages of using such an approach are: 1) the probe is genetically encoded, 2) ratiometric imaging allows one to assess redox status accurately regardless of the absolute levels of probe concentration due to expression, photobleaching or variation of tissue thickness, and 3) this method allows real time detection of redox status in different live cells and animal tissues without the permeation and preincubation of exogenous probes.
Studies of aging and various disease models in Drosophila would benefit from a genetically encoded means of measuring ROS within various tissues over a range of animal ages. We have generated roGFP transgenic flies bearing a mitochondrial or matrix target signal (MTS) fused to roGFP2 expressed in mitochondria (UAS-MTSroGFP2) and a cytosolic version (UAS-roGFPR12). Expression is conditional upon GAL4, allowing expression in various tissues using available 
